Endo announced a consumer level recall of one lot of clonazepam orally disintegrating 0.25 mg tablets because they may have been packaged in a carton labelled as 0.125 mg.
Classification Type: Class 1 Recall
Optum Clinical Services has sent a drug recall notification to potentially impacted members and providers. Below are the notification details.
|
Product
|
Clonazepam orally disintegrating 0.25 mg tablets
|
|
Manufacturer
|
Endo
|
|
Recall Identification date
|
07/09/2024
|
|
Affected NDCs
|
49884-307-02
|
|
Look back period
|
5/06/24 - 7/09/24
|
|
Target population for clinical mailing
|
All
|
|
Messaging type
|
Mailing: Members; Direct Message/Fax; Providers
|
|
Data release
|
SS00005114
|
|
Fulfillment due date for NCQA compliance
|
On or before: 07/29/2024
|
|
WHA impacted members
|
4 members
|
|
Date letters were mailed out
|
7/22/2024
|
Last review date: October 8, 2024